Walgreens Spearheads Advancement of Cell and Gene Therapies in Patient Care Expansion

Walgreens announces expansion into cell and gene therapy services in the U.S., aiming to provide specialized care for patients with chronic, rare, or complex conditions. The move includes the launch of a new business unit and the opening of a facility in Pittsburgh dedicated to cell and gene therapies, reflecting the growing importance of specialty pharmacies in the healthcare system. [ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said…

Johnson & Johnson tops quarterly profit estimates as medical device sales jump

Johnson & Johnson reports strong first-quarter earnings driven by surging sales in its medical devices business, with total revenue in line with expectations. The company also increases its quarterly dividend and provides updates on acquisitions and legal matters, including ongoing talc-related liabilities. [ad_1] An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business…

Surging inflation fears sent markets tumbling and Fed officials scrambling

[ad_1] A sign advertising units for rent is displayed outside of a Manhattan building on April 11, 2024 in New York City. Spencer Platt | Getty Images The early data is in for the path of inflation during the first three months of 2024, and the news so far is, well, not good. Pick your poison. Whether it’s prices at the register or wholesale input costs, while inflation is off the blistering pace of 2022, it doesn’t appear to be going away anytime soon. Future expectations also have been drifting…

Wholesale prices rose 0.2% in March, less than expected

[ad_1] A measure of wholesale prices increased less than expected in March, providing some potential relief from worries that inflation will hold higher for longer than many economists had expected. The producer price index rose 0.2% for the month, less than the 0.3% estimate from the Dow Jones consensus and not as much as the 0.6% increase in February, according to a release Thursday from the Labor Department’s Bureau of Labor Statistics. However, on a 12-month basis, the PPI climbed 2.1%, the biggest gain since April 2023, indicating pipeline pressures…

Hot inflation data pushes market’s rate cut expectations to September

[ad_1] Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City. Michael M. Santiago | Getty Images As recently as January, investors had high hopes that the Federal Reserve was about to embark on a rate-cutting campaign that would reverse some of the most aggressive policy tightening in decades. Three months of inflation data have brought those expectations back down to earth. March’s consumer price index report Wednesday helped verify worries that inflation is proving stickier than thought,…

Key Fed inflation gauge rose 2.8% annually in February, as expected

[ad_1] Inflation rose in line with expectations in February, likely keeping the Federal Reserve on hold before it can start considering interest rate cuts, according to a measure the central bank considers its more important barometer. The personal consumption expenditures price index excluding food and energy increased 2.8% on a 12-month basis and was up 0.3% from a month ago, the Commerce Department reported Friday. Both numbers matched the Dow Jones estimates. Including volatile food and energy costs, the headline PCE reading showed a 0.3% increase for the month and…

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy

[ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.  Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a “challenging” retail environment in the U.S. The company also posted a steep net loss for the quarter as it recorded a hefty nearly $6 billion charge related to the decline in value of its…